Dermatology 2026: Waxing Risks With New Therapies

The upcoming European Academy of Dermatology and Venereology (EADV) Congress in 2026 is going to be all about big changes in dermatology, particularly with emerging therapies like biologics and Janus kinase (JAK) inhibitors for conditions like psoriasis, eczema, and certain autoimmune disorders. While these drugs offer incredible relief for patients, for us in the treatment room, they throw a wrench into basic procedures like waxing. The real problem is we don’t fully get how these potent new medications interact with skin integrity and healing processes. So, how do we keep waxing a safe and effective option for clients on these advanced treatments?

The Unseen Risks: When New Therapies Meet Traditional Hair Removal

For as long as I can remember, our biggest waxing worries were simple: irritation, ingrown hairs, maybe an allergic reaction to a product. All things we can handle. But now, with these super-targeted biological agents and small molecule inhibitors that are the talk of events like EADV 2026, we’re in a whole new ballgame. These medications are revolutionary for chronic skin conditions because they modulate the immune system, but that same mechanism can seriously weaken the skin’s natural resilience. Think about a client on a Janus kinase (JAK) inhibitor for atopic dermatitis. Their skin might look less inflamed, but it could also be paper-thin and more susceptible to tearing or take forever to heal after a wax. We went through this exact learning curve with retinoids, where the increased cell turnover and thinned stratum corneum meant no waxing, period. This new generation of drugs presents similar, and sometimes more complicated, challenges.

In my experience, we only figure this out after the fact. A client comes back with crazy redness, sensitivity that won’t quit, or even minor skin lifting, and *then* we find out they’re on a new medication. Looking back after the damage is done is a total failure on our part. The problem isn’t the wax itself. It’s the complete lack of an integrated understanding between the medical and aesthetic communities about these powerful new pharmaceuticals. Without clear guidelines, estheticians are just guessing, working off anecdotes or vague warnings that might not even apply to the specific drug their client is taking.

What Went Wrong First: The Information Gap

The core of the problem has always been this massive information gap between the dermatologists prescribing these advanced therapies and the estheticians performing routine services. A patient can be perfectly educated about their condition and medication but will rarely connect that information to something as routine as a waxing appointment. They often assume that because their skin “looks better” from the medication, it must also be stronger. That is a dangerous assumption. Many systemic treatments, while improving the visible symptoms, can simultaneously compromise the skin barrier or alter its healing capacity on a microscopic level. For instance, some of the newer anti-inflammatory biologics suppress the body’s natural immune response, making the skin much more vulnerable to infection after waxing, yet our standard intake forms almost never ask about them specifically.

And let’s be fair, dermatologists are focused on managing the primary disease, so they aren’t always thinking about counseling patients on the implications for cosmetic procedures. The responsibility then falls to the aesthetic professional, who likely doesn’t have access to the latest pharmaceutical data or the medical training to interpret it. This broken system leads directly to inconsistent advice, unhappy clients, and in the worst-case scenarios, actual skin damage.

The Solution: A Collaborative and Proactive Framework for Waxing Safety

To fix this, we need a proactive plan built on better communication, more education, and updated protocols. The goal is to create a continuum of care that puts client safety first without unnecessarily telling everyone on these medications they can’t get waxed.

Step 1: Enhanced Pre-Service Consultation and Medical History Integration

Safe waxing for these clients starts with a much more detailed consultation, because our standard intake forms are completely outdated. We need to stop asking “Are you on any medications?” and start asking “Are you currently taking any prescription medications for skin conditions, including biologics, small molecule inhibitors, or oral retinoids?” Clients should be encouraged to bring a list of their current medications so we can see the exact names and dosages.

If a client identifies one of these emerging therapies, the next step isn’t to guess. You stop and recommend they get clearance from their prescribing dermatologist. This isn’t about passing the buck. It’s about getting informed consent and medical sign-off. A simple consent form, signed by the dermatologist, explicitly stating that waxing is deemed safe for their specific treatment plan can eliminate a huge amount of risk. The form should note the area to be waxed and the type of wax you plan to use (like a gentle hard wax), creating a clear line of communication.

It’s an extra step, sure, but this process builds an incredible amount of trust and ensures the client’s own medical team is part of the decision. We move from generic warnings to specific, actionable advice tailored to that individual.

Step 2: Specialized Training and Continuous Education for Professionals

As an industry, we have to get serious about continuing education that focuses on the dermatological impact of new drug classes. This has to go beyond basic pharmacology. We need to understand how biologics like the interleukin inhibitor dupilumab (used for eczema) or PDE4 inhibitors like crisaborole actually affect skin structure, healing, and sensitivity. Professional organizations should be developing modules on these topics, maybe even partnering with dermatological associations. I can easily see a certification program for “Advanced Aesthetic Care for Medicated Skin,” where we learn to identify contraindications and adapt our techniques.

This training needs to be practical, teaching us to recognize specific drug names, understand their mechanism of action in simple terms, and know the side effects most relevant to waxing. For example, knowing that some TNF-alpha inhibitors increase photosensitivity means you have to hammer home the SPF aftercare. Understanding that oral corticosteroids can thin the skin means you must adjust your application pressure and removal technique to prevent lifting. This is the level of detail required to make informed decisions and talk intelligently with clients.

Step 3: Adapting Waxing Protocols and Product Selection

For clients who get clearance for waxing while on these therapies, the protocols have to be adapted. This usually means defaulting to the gentlest methods available. Hard wax which encapsulates hair without adhering aggressively to the skin, is frequently a much safer choice than strip wax for compromised skin. Pre-waxing cleansers must be mild and pH-balanced, with no harsh astringents or exfoliants. The application technique itself needs to be modified, using smaller sections and paying careful attention to supporting the skin during removal to prevent any pulling.

Post-waxing care is just as critical. Clients need products designed to soothe, hydrate, and support the skin barrier, which means formulations rich in things like hyaluronic acid, ceramides, and anti-inflammatory botanicals. No products with strong fragrances, alcohols, or aggressive active ingredients that could irritate already sensitive skin. Plus, clients must be advised on strict sun protection and to avoid all harsh exfoliants for several days post-waxing. Some clinics are even exploring specialized post-waxing masks or serums tailored for medicated skin, offering an additional layer of protection and recovery.

This adaptation is not about inventing new procedures. It’s about refining existing ones with a heightened awareness of the client’s unique physiological state, which is the very definition of professional adaptability.

Measurable Results: Safer Services, Enhanced Trust, and Professional Growth

Do all this, and you’ll see real results. The most important one is a major drop in adverse reactions and complications for clients on these new dermatological therapies. When clients feel safe and understood, their trust in their esthetician deepens, which translates directly to better client retention and word-of-mouth referrals from people looking for a practitioner who gets their complex needs.

From a professional standpoint, this proactive approach also improves the standing of the entire aesthetic industry. It positions skin care professionals as integral members of a client’s wellness team, fostering stronger collaborative relationships with dermatologists. When a dermatologist can confidently refer a patient for waxing, knowing that the esthetician is well-versed in the nuances of their treatment, it creates a powerful teamwork. This collaboration can even lead to shared educational initiatives, finally bridging the gap between medical and aesthetic practices.

By making these changes, we’re providing a service that’s informed, safe, and in sync with modern medical science. This is how the aesthetic industry stays relevant and indispensable in a world of constant medical advancement. It’s how we get ready for what EADV 2026 brings, and for all the innovations that will follow.